跳至主要内容
临床试验/NCT02141139
NCT02141139Unknown3 期

Suppression of Inflammation by Using NSAIDs During Peri-operative Period Can Affect the Prognosis of Breast Cancer.

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 1,568 人开始时间: 2014年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
1,568
试验地点
1
主要终点
disease free survival

研究概览

简要总结

It is increasingly recognized the NSAIDS (nonsteroidal antiinflammatory drug) might prevent the several cancers. In breast cancer, the role of NSAIDS (nonsteroidal antiinflammatory drug) has been suggested.However, there was no consistent results. surgery is main cause of inflammation for cancer patients. Therefore, we want to know the association between prevention of perioperative inflammation with NSAIDS and breast cancer outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Breast cancer patients who took the surgery

排除标准

  • underlying medical disease (major heart disease, lung disease, coagulopathy)
  • major psychologic disease (major depression, schizophrenia, manic disorder)
  • pregnancy
  • rheumatic disease patients

研究组 & 干预措施

NSAIDS (ketorolac intravenous, ibuprofen)

Experimental

ketorolac IV (just before surgery) and ibuprofen for 1 weeks

干预措施: NSAIDS (ketorolac and ibuprofen) (Drug)

结局指标

主要结局

disease free survival

时间窗: 5 years

次要结局

  • overall survival(5years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Seok Jin Nam

Professor

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验